Albumin

Physiological Role

Albumin is the most abundant protein in blood plasma. It accounts for nearly 60% of circulating proteins. Its synthesis is carried out exclusively by the liver, at a rate of 10 to 15 grams per day in healthy adults.

Its first function is transport. Albumin binds and carries many molecules across the circulation: thyroid and steroid hormones, non-esterified fatty acids, calcium, bilirubin, and numerous drugs. This transport capacity rests on its three-dimensional structure, which exposes several high-affinity binding sites.

Its second function is the maintenance of oncotic pressure. By retaining water in the vascular compartment, albumin stabilizes plasma volume and participates in the fluid balance between blood and tissues. It also constitutes a mobilizable protein reserve when dietary intake becomes insufficient.

Hepatic albumin synthesis is regulated by amino acid availability and the hormonal environment. It is inhibited by pro-inflammatory cytokines such as interleukin-6, which makes albumin a so-called negative acute-phase reactant: its level falls in response to chronic inflammation.

Reference Ranges

These reference ranges are derived from scientific literature and may differ from your laboratory's reference values.

Source : Zhang C et al. / Heliyon (community-dwelling elderly cohort) (2024)

Biological Significance

Albumin in the optimal range reflects a satisfactory balance between hepatic synthesis, dietary protein intake, and the absence of low-grade systemic inflammation. This is the profile associated with the best aging trajectories in longevity cohorts.

Values below the optimum may signal a convergence of several factors. Hepatic synthesis may be reduced, protein intake suboptimal, or chronic low-grade inflammation may limit production. In individuals over 60, this profile is associated with increased frailty and a higher risk of sarcopenia. Recent scientific literature documents a marked rise in all-cause mortality risk below a vigilance threshold.

Elevated values typically reflect transient dehydration. The plasma becomes more concentrated, which artificially raises the measurement. Good hydration before sampling avoids this misleading interpretation.

Albumin reading gains precision when cross-referenced with other markers. Liver transaminases inform on hepatic function, hs-CRP on chronic inflammation, and the trend over time matters more than any single isolated value.

Influencing Factors

Protein intake. Hepatic albumin synthesis depends directly on amino acid availability. Adequate protein intake, distributed across the day and including complete sources, supports albumin production.

Chronic inflammation. Pro-inflammatory cytokines, particularly interleukin-6, actively inhibit hepatic albumin synthesis. Persistent elevation of hs-CRP is often accompanied by a parallel decline in albumin. This inverse relationship is well documented in the longevity literature.

Liver function. Since the liver is the only organ synthesizing albumin, any alteration of its function can be reflected in the measured level. Reading albumin alongside ALT and GGT helps refine this interpretation.

Hydration. Hydration status at the time of sampling influences the measured concentration. Moderate dehydration concentrates the plasma and artificially raises albumin. Good hydration in the 24 hours before blood collection improves result reliability.

Age. Hepatic albumin synthesis gradually declines with age. This trend contributes to the average decrease observed after 70. Maintaining albumin in the optimal range during this decade is a marker of successful aging.

Physical activity. Regular exercise indirectly supports albumin synthesis. Resistance training, combined with sufficient protein intake, stimulates overall protein metabolism and contributes to chronic inflammation reduction.

Bioactives. Several Singular bioactives can indirectly influence albumin levels. Glycine, a non-essential amino acid involved in nitrogen metabolism, supports the available amino acid pool. Omega-3 EPA+DHA and curcumin, whose influence on chronic inflammation is documented in the literature, contribute to a biological environment favorable to hepatic synthesis. N-acetylcysteine supports hepatic defense pathways.

In the Singular Formula

Albumin holds a particular place in the Singular formulation engine. It does not trigger a direct adjustment on a specific bioactive, but serves as an interpretive marker for other biomarkers.

Circulating vitamin B6 is measured in its active form, pyridoxal-5-phosphate (PLP). PLP circulates predominantly bound to plasma albumin. When albumin is in the low or very low range, PLP interpretation becomes more delicate. A low PLP may reflect actual insufficient B6 intake or simply reduced transport capacity. In this configuration, the formulation engine applies a cautious B6 dosage. This caution remains in place until albumin returns to the optimal range and a more reliable reading of B6 status becomes possible.

Beyond this interpretive logic, albumin is part of the bundle of markers that compose the global biological profile. It is read in parallel with ALT and GGT for hepatic synthetic function, and with hs-CRP for chronic inflammation. These cross-readings allow the engine to distinguish a low albumin linked to suboptimal protein intake from a low albumin secondary to chronic inflammation.

Several Singular bioactives can indirectly contribute to a biological environment favorable to albumin synthesis. Glycine provides a glucogenic amino acid often limiting in modern nutritional profiles. N-acetylcysteine, a glutathione precursor, supports hepatic defense pathways. Curcumin and omega-3 EPA+DHA, whose influence on chronic inflammation is documented in the literature, may modulate the biological context in which the liver produces albumin. These bioactives are not adjusted in response to albumin itself, but their presence in the formula can indirectly support the conditions of its synthesis.

Scientific Studies

Frequently Asked Questions